(Q63811619)
Statements
A Phase III, Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Clinical Trial to Investigate the Efficacy and Safety of BX-1 for the Symptomatic Relief of Spasticity in Patients With Multiple Sclerosis (MS) (English)
0 references
18 February 2019
0 references
July 2020
0 references
384
0 references
18 year
0 references
65 year
0 references